Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Viking Therapeutics, Inc. (VKTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/18/2023 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 40,000 shares
@ $25, valued at
$1M
Exercised 40,000 options to buy
@ $1.08, valued at
$43.2k
|
|
| 05/18/2023 |
4
| MACARTNEY LAWSON (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 16,000 shares
@ $24, valued at
$384k
Exercised 16,000 options to buy
@ $1.19, valued at
$19k
|
|
| 05/01/2023 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 45,000 shares
@ $22.45, valued at
$1M
|
|
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 88,000 shares
@ $16.95, valued at
$1.5M
Sold 65,382 shares
@ $17.45, valued at
$1.1M
Sold 67,970 shares
@ $17.45, valued at
$1.2M
Sold 22,000 shares
@ $17.85, valued at
$392.7k
Granted 300,000 shares
@ $0
Paid exercise price by delivering 200,000 shares
@ $17.57, valued at
$3.5M
Exercised 115,852 options to buy
@ $1.23, valued at
$142.5k
Exercised 19,530 options to buy
@ $9.49, valued at
$185.3k
Exercised 67,970 options to buy
@ $9.49, valued at
$645k
|
|
| 04/03/2023 |
4
| ZANTE GREG (CFO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 131,029 shares
@ $17.0025, valued at
$2.2M
Sold 30,911 shares
@ $18, valued at
$556.4k
Granted 56,667 shares
@ $0
Paid exercise price by delivering 55,166 shares
@ $17.57, valued at
$969.3k
Exercised 32,000 options to buy
@ $8.52, valued at
$272.6k
Exercised 42,000 options to buy
@ $7.69, valued at
$323k
Exercised 12,250 options to buy
@ $4.65, valued at
$57k
Exercised 7,500 options to buy
@ $4.12, valued at
$30.9k
Exercised 30,911 options to buy
@ $7.77, valued at
$240.2k
|
|
| 04/03/2023 |
4
| Mancini Marianna (COO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Exercised 36,100 shares
@ $17.0091, valued at
$614k
Granted 56,667 shares
@ $0
Paid exercise price by delivering 30,799 shares
@ $17.57, valued at
$541.1k
Exercised 23,100 options to buy
@ $8.52, valued at
$196.8k
Exercised 10,000 options to buy
@ $7.69, valued at
$76.9k
Exercised 3,000 options to buy
@ $6.47, valued at
$19.4k
|
|
| 03/30/2023 |
4
| Mancini Marianna (COO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 196,563 shares
@ $15, valued at
$2.9M
Sold 41,242 shares
@ $16, valued at
$659.9k
Exercised 15,000 options to buy
@ $2.15, valued at
$32.3k
Exercised 4,873 options to buy
@ $1.88, valued at
$9.2k
Exercised 15,000 options to buy
@ $1.26, valued at
$18.9k
Exercised 53,054 options to buy
@ $1.23, valued at
$65.3k
Exercised 15,000 options to buy
@ $1.08, valued at
$16.2k
Exercised 10,000 options to buy
@ $1.04, valued at
$10.4k
Exercised 24,500 options to buy
@ $4.65, valued at
$113.9k
Exercised 30,000 options to buy
@ $4.37, valued at
$131.1k
Exercised 15,000 options to buy
@ $9.13, valued at
$137k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| ZANTE GREG (CFO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 20,233 shares
@ $0
Paid exercise price by delivering 19,697 shares
@ $9.4, valued at
$185.2k
Granted 90,667 shares
@ $0
Paid exercise price by delivering 23,933 shares
@ $8.52, valued at
$203.9k
Paid exercise price by delivering 20,708 shares
@ $8.42, valued at
$174.4k
Granted 204,000 options to buy
@ $8.52, valued at
$1.7M
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| MACARTNEY LAWSON (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $8.52, valued at
$187.4k
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Mancini Marianna (COO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 827 shares
@ $4.24, valued at
$3.5k
|
|
| 01/05/2022 |
4
| ZANTE GREG (CFO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,097 shares
@ $4.88, valued at
$15.1k
Granted 53,333 shares
@ $0
Paid exercise price by delivering 8,835 shares
@ $4.62, valued at
$40.8k
Granted 120,000 options to buy
@ $4.88, valued at
$585.6k
|
|
| 01/05/2022 |
4
| Mancini Marianna (COO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,919 shares
@ $4.88, valued at
$19.1k
Granted 77,333 shares
@ $0
Paid exercise price by delivering 11,845 shares
@ $4.62, valued at
$54.7k
Granted 174,000 options to buy
@ $4.88, valued at
$849.1k
|
|
| 01/05/2022 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 36,319 shares
@ $4.88, valued at
$177.2k
Granted 173,333 shares
@ $0
Paid exercise price by delivering 26,432 shares
@ $4.62, valued at
$122.1k
Granted 390,000 options to buy
@ $4.88, valued at
$1.9M
|
|
| 01/05/2022 |
4
| SINGLETON J MATTHEW (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
| 01/05/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
| 01/05/2022 |
4
| Rouan Sarah Kathryn (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
| 01/05/2022 |
4
| MACARTNEY LAWSON (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
| 01/05/2022 |
4
| FOEHR MATTHEW W (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
|
|
|